Elizabeth Migoya - Concepedia

Author

Elizabeth Migoya

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

E M Migoya, E MIGOYA, E Migoya, E. Migoya, E.M. Migoya, Elizabeth M Migoya, Elizabeth M. Migoya, Elizabeth Migoya

Publications

906

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Myovant Sciences (United States)United States Military Academy Clinical Research Associates Children's Mercy Hospital

About

Elizabeth Migoya is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	349
2	Allergy	1	1	43
3	Biostatistics	1	1	14
4	Diabetes	1	1	20
5	Endocrinology	1	1	14

Elizabeth Migoya

Publications

862

Citations

H-Index

Page 1

	Year	Citations
Dipeptidyl Peptidase-4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP-1 Elizabeth Migoya, Raynald Bergeron, Jutta Miller, Clinical Pharmacology & Therapeutics	2010	175
Disposition of Caspofungin: Role of Distribution in Determining Pharmacokinetics in Plasma Julie A. Stone, Xin Xu, Gregory A. Winchell, Antimicrobial Agents and Chemotherapy Physiologically-based Pharmacokinetic ModelingMedicineParenteral Antifungal DrugRadioactivity ExcretionPathology	2004	137
Potential for Interactions between Caspofungin and Nelfinavir or Rifampin Julie A. Stone, Elizabeth Migoya, Lisa Hickey, Antimicrobial Agents and Chemotherapy	2004	98
Single‐ and Multiple‐Dose Administration of Caspofungin in Patients With Hepatic Insufficiency: Implications for Safety and Dosing Recommendations Goutam C. Mistry, Elizabeth Migoya, Paul Deutsch, The Journal of Clinical Pharmacology Hepatic InsufficiencyDosage AdjustmentHepatologyLiver PhysiologyPharmacology	2007	64
Effect of moderate hepatic insufficiency on the pharmacokinetics of sitagliptin. Elizabeth Migoya, Catherine Stevens, Arthur Bergman, PubMed	2009	58
Pharmacokinetics of Montelukast in Asthmatic Patients 6 to 24 Months Old Elizabeth Migoya, Gregory L. Kearns, Alan Hartford, The Journal of Clinical Pharmacology AsthmaAsthmatic Patients 6AllergyMedicineComparability Bounds	2004	43
Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants Elizabeth Migoya, Goutam C. Mistry, Julie A. Stone, The Journal of Clinical Pharmacology	2010	31
Pharmacokinetics and Safety of Montelukast Oral Granules in Children 1 to 3 Months of Age With Bronchiolitis Gregory L. Kearns, Susan Lu, Lata Maganti, The Journal of Clinical Pharmacology AsthmaDrug SafetyPharmacologyPediatricsPediatric Lung Disease	2008	28
Pharmacokinetics and Safety of Montelukast in Children Aged 3 to 6 Months Barbara Knorr, Lata Maganti, Rohini Ramakrishnan, The Journal of Clinical Pharmacology	2006	28
Effect of Cefiderocol, a Siderophore Cephalosporin, on QT/QTc Interval in Healthy Adult Subjects Carlos Sanabria, Elizabeth Migoya, Jay W. Mason, Clinical Therapeutics	2019	25

Page 1